Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
about
Integrins in the Spotlight of CancerL-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinomaPrognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinomaSpecific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.ASCT2 regulates glutamine uptake and cell growth in endometrial carcinomaMiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.Neurodegeneration and the Brain Tumor Microenvironment. [corrected]Application value of MRI combined with positron emission tomography (PET)/CT in diagnosis and preoperative staging of tongue squamous cell carcinoma.Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells.Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo.Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer.(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse modelAn anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models
P2860
Q28066805-5F7E0DA2-78B3-4459-9C00-75BBFA813ED7Q35757977-415F75EF-E1C8-4B47-B0A8-2587C87C2715Q35941321-E51E8AE6-1029-4166-B311-B093E79E77A5Q35941337-970255F0-D83F-4EF8-A69E-A13767903394Q35986621-F681D03A-5B76-4B44-BA23-F11A153037EDQ36012992-37DFAAB8-25A6-4900-A975-83540133358AQ36310209-1ECA27FA-8963-44EF-9AEF-22359085A218Q36746299-69CF73BE-783E-46C6-B77B-4C2BA596D82DQ37375216-90A3FCF1-4B4D-4209-870A-241EC018EFC1Q38651973-69EAF8C6-4370-49D1-B061-4A54C760F1F9Q38699922-2FE1D050-6036-4C51-9D6E-47920E4D5C36Q38754089-EFBA1AAB-A8F6-45DC-BAC9-97748F129BF5Q38772674-A92304B9-5BCB-496E-B907-77670F4615D5Q39112756-DB25A221-A8BE-482E-8BE6-700A192D7C1EQ40494622-FD3E0D3D-95C6-4377-B1F4-231CA4909C7CQ41262739-1C7016C5-177A-4E87-AE9D-3825A772552BQ41573099-6166B687-249A-4993-8CC1-A214B996A507Q42229244-B7F4DDA6-A9B5-4957-977C-BC48DEE22BA9Q42722024-B03E51D9-BE59-4DE2-8B21-D65AD30D98D7Q46913425-D3EFB3AC-5430-4050-B3A1-2ED932A41F4BQ47833074-C30B28AC-66D7-4745-BC3D-7E8158192F06Q48277237-49F33391-A9AE-4959-BCF7-37DE194CF274Q50952257-355907DC-5504-4862-AD4A-9441B8A8A7E3Q52719810-15A0C0AA-7C37-4A51-A0BC-B313EE1A5FFAQ52724909-8ABEFEE7-0EB8-48C6-9E84-DCC914020EC9Q58706948-582FF350-2BFD-4E70-9F18-D679F630563AQ58804578-F9A31A5A-31DF-4C7E-8E1E-4F96BBD86233
P2860
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic significance of ami ...... ically resected tongue cancer.
@ast
Prognostic significance of ami ...... ically resected tongue cancer.
@en
type
label
Prognostic significance of ami ...... ically resected tongue cancer.
@ast
Prognostic significance of ami ...... ically resected tongue cancer.
@en
prefLabel
Prognostic significance of ami ...... ically resected tongue cancer.
@ast
Prognostic significance of ami ...... ically resected tongue cancer.
@en
P2093
P2860
P356
P1476
Prognostic significance of ami ...... gically resected tongue cancer
@en
P2093
H Tominaga
K Chikamatsu
K Sakakura
K Takahashi
N S Ishioka
S Nagamori
P2860
P2888
P304
P356
10.1038/BJC.2014.178
P407
P577
2014-04-24T00:00:00Z
P5875
P6179
1011137789